ZYXIQ · ZYNEX INC
Going-concern doubt
— flagged Nov 17, 2025
Substantial doubt about the company's ability to continue as a going concern.
“Because certain elements of management's plans to mitigate the conditions that raised substantial doubt about the Company's ability to continue as a going concern are outside of the Company's control, including the ability to raise capital through an equity or other financing, those elements cannot be considered probable according to ASC 205-40, and therefore cannot be considered in the evaluation of mitigating factors. As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date the unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Nov 17, 2025
Market Cap
$1.69M
Shares
30.39M
Volume
—
Avg daily vol (3M)
—
No Price Data
No daily price data is available for this stock yet. Data syncs automatically.
Up next
filed Nov 17, 2025
call held Nov 17, 2025
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Limited
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.87% of float · ▲ +1.0% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Revenue growth
+4%
Y/Y
Gross margin
7%
contracting
EPS growth
−67%
Y/Y
Free cash flow
$12.1M
Balance sheet
$9.5M
net cash
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guided vs delivered
· last 8 settled
Third quarter 2024 revenue
Third quarter 2024
guided at least $50M
$49.97M
Miss −0.1%
Diluted EPS
Third quarter 2024
guided at least $0.05
$0.07
In line
Revenue
Q2 2024
guided at least $52M
$49.88M
Miss −4.1%
Diluted EPS
Q2 2024
guided at least $0.08
$0.04
Miss −50.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZYXIQ
this stock
ZYNEX INC
|
$1.69M | — | +4.4% | — | 3.9% |
|
MCK
Mckesson Corp
|
$101.04B | +10.0% | +3.1% | 23.3 | 2.5% |
|
COR
Cencora, Inc.
|
$57.74B | -8.5% | +9.3% | 22.5 | 2.3% |
|
CAH
Cardinal Health Inc
|
$52.08B | +11.1% | +14.2% | — | 2.9% |
|
HSIC
Henry Schein Inc
|
$9.63B | +12.3% | +5.9% | 25.2 | 6.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events